To The Moon
Home
News
TigerAI
Log In
Sign Up
benjaminlsk
+Follow
Posts · 35
Posts · 35
Following · 0
Following · 0
Followers · 0
Followers · 0
benjaminlsk
benjaminlsk
·
2022-02-24
This is it bois and ladies
Dow Plunges More Than 800 Points as Russia Attacks Ukraine, Nasdaq Falls into Bear Market Territory
Stocks fell sharply Thursday as Russia attacked Ukraine, causing global energy prices to jump and se
Dow Plunges More Than 800 Points as Russia Attacks Ukraine, Nasdaq Falls into Bear Market Territory
看
4.66K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-23
Where tsla
EV Stocks Rebounded in Morning Trading, with TuSimple Rising Nearly 5% and General Motors,Li Rising Around 2%
EV stocks rebounded in morning trading, with TuSimple rising nearly 5% and General Motors,Li rising
EV Stocks Rebounded in Morning Trading, with TuSimple Rising Nearly 5% and General Motors,Li Rising Around 2%
看
5.00K
回复
Comment
点赞
10
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-22
Hi
Sorry, this post has been deleted
看
4.69K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-21
Moon
Sorry, this post has been deleted
看
4.56K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-18
Nice
Bristol Myers' Breyanzi Gets FDA Priority Review for Expanded Use in Blood Cancer Subtype
The U.S. Food and Drug Administration (FDA) granted priority review for expanded use of Bristol Myer
Bristol Myers' Breyanzi Gets FDA Priority Review for Expanded Use in Blood Cancer Subtype
看
4.80K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-17
Nice
Walmart Bucks Supply-Chain Snarls With Upbeat Annual Outlook
(Bloomberg) -- Walmart Inc. surpassed Wall Street’s quarterly profit expectations and unveiled an up
Walmart Bucks Supply-Chain Snarls With Upbeat Annual Outlook
看
4.50K
回复
Comment
点赞
6
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-16
Nice
Two Reasons to Skip Ocugen Stock Despite Some Good News
Ocugen(NASDAQ:OCGN) has been one of the most explosive stocks on the market in the last year.From a
Two Reasons to Skip Ocugen Stock Despite Some Good News
看
3.94K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-15
Oof
Larimar Therapeutics Shares Tumbled 54.6% in Premarket Trading
Larimar Therapeutics shares tumbled 54.6% in premarket trading.Larimar Therapeutics, Inc. (“Larimar”
Larimar Therapeutics Shares Tumbled 54.6% in Premarket Trading
看
4.76K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-14
Nice
Sorry, this post has been deleted
看
4.84K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
benjaminlsk
benjaminlsk
·
2022-02-12
Wow
Under Armour Shares Slid 7% in Morning Trading
Under Armour Class A/C Shares Both Slid 7% in Morning Trading. Under Armour Warned of Margin Hit Du
Under Armour Shares Slid 7% in Morning Trading
看
4.55K
回复
Comment
点赞
6
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3571707309049146","uuid":"3571707309049146","gmtCreate":1608614552558,"gmtModify":1608614552558,"name":"benjaminlsk","pinyin":"benjaminlsk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":"https://static.tigerbbs.com/ae1f49570794979e009a5efdeb6f4789","hatId":"ca_profile_frame_ugQHMi","hatName":"","vip":1,"status":2,"fanSize":1,"headSize":6,"tweetSize":35,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"93.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"80.75%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9030652648,"gmtCreate":1645714845251,"gmtModify":1676534056655,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"This is it bois and ladies","listText":"This is it bois and ladies","text":"This is it bois and ladies","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030652648","repostId":"1153236103","repostType":4,"repost":{"id":"1153236103","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1645713014,"share":"https://ttm.financial/m/news/1153236103?lang=en_US&edition=fundamental","pubTime":"2022-02-24 22:30","market":"us","language":"en","title":"Dow Plunges More Than 800 Points as Russia Attacks Ukraine, Nasdaq Falls into Bear Market Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=1153236103","media":"Tiger Newspress","summary":"Stocks fell sharply Thursday as Russia attacked Ukraine, causing global energy prices to jump and se","content":"<html><head></head><body><p>Stocks fell sharply Thursday as Russia attacked Ukraine, causing global energy prices to jump and sending investors fleeing for the safety of fixed income assets.</p><p>The invasion comes as global equity markets were already reeling because of decades-high inflation stemming from the pandemic.</p><p>The S&P 500 was down 2.5%, as the benchmark plunged further into correction territory. The index closed Wednesday 12% off its record high. The Dow Jones Industrial Average fell 810 points, or 2.4%. The blue-chip measure closed Wednesday more than 10% off its record. The Nasdaq Composite declined 3%. The Nasdaq Composite is teetering on bear market territory, down just less than 20% from its high through Wednesday’s close.</p><p>Moscow launched the military action in Ukraineovernight Thursday. There were reports of explosions and missile strikes on several key Ukrainian cities including its capital, Kyiv. Russian President Vladimir Putin called the invasion “the demilitarization” of Ukraine and said Russia’s plans do not include the occupation of Ukrainian territories.</p><p>NATO, the most powerful military alliance in the world, is set to reinforce its presence on its eastern front following Russia’s invasion of Ukraine. President Joe Biden condemned the attack, saying in a statement that “the world hold Russia accountable.”</p><p>“Russia alone is responsible for the death and destruction this attack will bring, and the United States and its Allies and partners will respond in a united and decisive way,” Biden said.</p><p>The Russia invasion “is really worse than a baseline expectation that we had or the markets had. I would argue we are talking basically another 5% to 6% down which would put us close to 20% or bear market territory,” said Binky Chadha, chief U.S. equity and global strategist at Deutsche Bank,” on CNBC’s “Squawk Box” Thursday.</p><p>Global oil benchmark Brent jumped 7.7% to $104.56per barrel, passing the $100 level for the first time since 2014. The U.S. oil benchmark, WTI, traded 7.2% higher at just shy of $100 per barrel. Natural gas pricessurged5%.</p><p>Treasury prices increased and yields tumbled, with the benchmark 10-year note rate declining to 1.86% as investors sought safe-haven bonds. The move reversed a ramp in yields that took the 10-year well above 2% earlier in the session. Gold futures increased 3.2% to $1,970 an ounce as investors sought other safe havens. TheCboe Volatility index, a gauge of Wall Street fear, spiked to above the 37 level on Thursday, near hits highest levels of the year.</p><p>European stocks sold off sharply on Thursday after Russia began an attack on Ukraine, tipping a longstanding diplomatic crisis into a military conflict. The pan-European Stoxx 600 dropped 3.6% to its lowest point of the year.</p><p>The VanEck Russia ETF, a U.S.-traded security which invests in top Russian companies,dropped nearly 25% in premarket trading on Thursday.</p><p>“The worst-case scenario of Russia invading Ukraine beyond the separatist regions is a shock to the equity and oil markets. The fallout could have sizeable negative impact on the European economy which would then dampen US activity modestly,” said Kathy Bostjancic, chief U.S. economist at Oxford Economics. “In the face of such uncertainty and negative economic fallout, the Fed is likely to raise the policy rate just 25bps in March, but it will still move forward.”</p><p>It was a broad sell-off with investors selling shares en masse. Apple was down 4% in premarket trading. Bank of America and JPMorgan Chase lost more than 3% each. Tesla was 7% lower in early trading.</p><p>Among the few stocks in the green were energy and defense stocks. Devon Energy was up 5% and Chevron rose 4.2% in premarket trading. Lockheed Martin and Raytheon Technologies gained 2% apiece.</p><p>Bitcoinwas getting hammered,most recently down 6.5%to $35,207.50 as investors shed risk.</p><p>“Investors should expect strong sanctions imposed on Russia, which will slow growth and leave upward pressure on commodity prices,” wrote Dennis DeBusschere of 22V Research. “How long this crisis takes to unfold will determine how much inflation, financial conditions, and growth will be impacted. Short-term, a flight to safety means Treasury yields, rate hike expectations and risk assets are sharply lower.”</p><p>The Ukraine situation has added to tensions for the market, which had been worried about tighter Federal Reserve policy amid escalating inflation. Traders have adjusted their views on the Fed in recent days, with the likelihood of a 0.5 percentage point interest rate hike in March down to 17%, according to CME Group data.</p><p>Wednesday marked another downbeat market session on Wall Street, as traders grappled with the ongoing Russia-Ukraine conflict.</p><p>In the Wednesday session, the Dow dropped about 464 points, or 1.3%, and closed at its lowest level of 2022 so far. The S&P 500 fell 1.8%, moving deeper into correction and ending the day about 12% from its Jan. 3 record close. The tech-heavy Nasdaq Composite lost 2.6% and now sits close to bear market territory.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow Plunges More Than 800 Points as Russia Attacks Ukraine, Nasdaq Falls into Bear Market Territory</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow Plunges More Than 800 Points as Russia Attacks Ukraine, Nasdaq Falls into Bear Market Territory\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-24 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Stocks fell sharply Thursday as Russia attacked Ukraine, causing global energy prices to jump and sending investors fleeing for the safety of fixed income assets.</p><p>The invasion comes as global equity markets were already reeling because of decades-high inflation stemming from the pandemic.</p><p>The S&P 500 was down 2.5%, as the benchmark plunged further into correction territory. The index closed Wednesday 12% off its record high. The Dow Jones Industrial Average fell 810 points, or 2.4%. The blue-chip measure closed Wednesday more than 10% off its record. The Nasdaq Composite declined 3%. The Nasdaq Composite is teetering on bear market territory, down just less than 20% from its high through Wednesday’s close.</p><p>Moscow launched the military action in Ukraineovernight Thursday. There were reports of explosions and missile strikes on several key Ukrainian cities including its capital, Kyiv. Russian President Vladimir Putin called the invasion “the demilitarization” of Ukraine and said Russia’s plans do not include the occupation of Ukrainian territories.</p><p>NATO, the most powerful military alliance in the world, is set to reinforce its presence on its eastern front following Russia’s invasion of Ukraine. President Joe Biden condemned the attack, saying in a statement that “the world hold Russia accountable.”</p><p>“Russia alone is responsible for the death and destruction this attack will bring, and the United States and its Allies and partners will respond in a united and decisive way,” Biden said.</p><p>The Russia invasion “is really worse than a baseline expectation that we had or the markets had. I would argue we are talking basically another 5% to 6% down which would put us close to 20% or bear market territory,” said Binky Chadha, chief U.S. equity and global strategist at Deutsche Bank,” on CNBC’s “Squawk Box” Thursday.</p><p>Global oil benchmark Brent jumped 7.7% to $104.56per barrel, passing the $100 level for the first time since 2014. The U.S. oil benchmark, WTI, traded 7.2% higher at just shy of $100 per barrel. Natural gas pricessurged5%.</p><p>Treasury prices increased and yields tumbled, with the benchmark 10-year note rate declining to 1.86% as investors sought safe-haven bonds. The move reversed a ramp in yields that took the 10-year well above 2% earlier in the session. Gold futures increased 3.2% to $1,970 an ounce as investors sought other safe havens. TheCboe Volatility index, a gauge of Wall Street fear, spiked to above the 37 level on Thursday, near hits highest levels of the year.</p><p>European stocks sold off sharply on Thursday after Russia began an attack on Ukraine, tipping a longstanding diplomatic crisis into a military conflict. The pan-European Stoxx 600 dropped 3.6% to its lowest point of the year.</p><p>The VanEck Russia ETF, a U.S.-traded security which invests in top Russian companies,dropped nearly 25% in premarket trading on Thursday.</p><p>“The worst-case scenario of Russia invading Ukraine beyond the separatist regions is a shock to the equity and oil markets. The fallout could have sizeable negative impact on the European economy which would then dampen US activity modestly,” said Kathy Bostjancic, chief U.S. economist at Oxford Economics. “In the face of such uncertainty and negative economic fallout, the Fed is likely to raise the policy rate just 25bps in March, but it will still move forward.”</p><p>It was a broad sell-off with investors selling shares en masse. Apple was down 4% in premarket trading. Bank of America and JPMorgan Chase lost more than 3% each. Tesla was 7% lower in early trading.</p><p>Among the few stocks in the green were energy and defense stocks. Devon Energy was up 5% and Chevron rose 4.2% in premarket trading. Lockheed Martin and Raytheon Technologies gained 2% apiece.</p><p>Bitcoinwas getting hammered,most recently down 6.5%to $35,207.50 as investors shed risk.</p><p>“Investors should expect strong sanctions imposed on Russia, which will slow growth and leave upward pressure on commodity prices,” wrote Dennis DeBusschere of 22V Research. “How long this crisis takes to unfold will determine how much inflation, financial conditions, and growth will be impacted. Short-term, a flight to safety means Treasury yields, rate hike expectations and risk assets are sharply lower.”</p><p>The Ukraine situation has added to tensions for the market, which had been worried about tighter Federal Reserve policy amid escalating inflation. Traders have adjusted their views on the Fed in recent days, with the likelihood of a 0.5 percentage point interest rate hike in March down to 17%, according to CME Group data.</p><p>Wednesday marked another downbeat market session on Wall Street, as traders grappled with the ongoing Russia-Ukraine conflict.</p><p>In the Wednesday session, the Dow dropped about 464 points, or 1.3%, and closed at its lowest level of 2022 so far. The S&P 500 fell 1.8%, moving deeper into correction and ending the day about 12% from its Jan. 3 record close. The tech-heavy Nasdaq Composite lost 2.6% and now sits close to bear market territory.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153236103","content_text":"Stocks fell sharply Thursday as Russia attacked Ukraine, causing global energy prices to jump and sending investors fleeing for the safety of fixed income assets.The invasion comes as global equity markets were already reeling because of decades-high inflation stemming from the pandemic.The S&P 500 was down 2.5%, as the benchmark plunged further into correction territory. The index closed Wednesday 12% off its record high. The Dow Jones Industrial Average fell 810 points, or 2.4%. The blue-chip measure closed Wednesday more than 10% off its record. The Nasdaq Composite declined 3%. The Nasdaq Composite is teetering on bear market territory, down just less than 20% from its high through Wednesday’s close.Moscow launched the military action in Ukraineovernight Thursday. There were reports of explosions and missile strikes on several key Ukrainian cities including its capital, Kyiv. Russian President Vladimir Putin called the invasion “the demilitarization” of Ukraine and said Russia’s plans do not include the occupation of Ukrainian territories.NATO, the most powerful military alliance in the world, is set to reinforce its presence on its eastern front following Russia’s invasion of Ukraine. President Joe Biden condemned the attack, saying in a statement that “the world hold Russia accountable.”“Russia alone is responsible for the death and destruction this attack will bring, and the United States and its Allies and partners will respond in a united and decisive way,” Biden said.The Russia invasion “is really worse than a baseline expectation that we had or the markets had. I would argue we are talking basically another 5% to 6% down which would put us close to 20% or bear market territory,” said Binky Chadha, chief U.S. equity and global strategist at Deutsche Bank,” on CNBC’s “Squawk Box” Thursday.Global oil benchmark Brent jumped 7.7% to $104.56per barrel, passing the $100 level for the first time since 2014. The U.S. oil benchmark, WTI, traded 7.2% higher at just shy of $100 per barrel. Natural gas pricessurged5%.Treasury prices increased and yields tumbled, with the benchmark 10-year note rate declining to 1.86% as investors sought safe-haven bonds. The move reversed a ramp in yields that took the 10-year well above 2% earlier in the session. Gold futures increased 3.2% to $1,970 an ounce as investors sought other safe havens. TheCboe Volatility index, a gauge of Wall Street fear, spiked to above the 37 level on Thursday, near hits highest levels of the year.European stocks sold off sharply on Thursday after Russia began an attack on Ukraine, tipping a longstanding diplomatic crisis into a military conflict. The pan-European Stoxx 600 dropped 3.6% to its lowest point of the year.The VanEck Russia ETF, a U.S.-traded security which invests in top Russian companies,dropped nearly 25% in premarket trading on Thursday.“The worst-case scenario of Russia invading Ukraine beyond the separatist regions is a shock to the equity and oil markets. The fallout could have sizeable negative impact on the European economy which would then dampen US activity modestly,” said Kathy Bostjancic, chief U.S. economist at Oxford Economics. “In the face of such uncertainty and negative economic fallout, the Fed is likely to raise the policy rate just 25bps in March, but it will still move forward.”It was a broad sell-off with investors selling shares en masse. Apple was down 4% in premarket trading. Bank of America and JPMorgan Chase lost more than 3% each. Tesla was 7% lower in early trading.Among the few stocks in the green were energy and defense stocks. Devon Energy was up 5% and Chevron rose 4.2% in premarket trading. Lockheed Martin and Raytheon Technologies gained 2% apiece.Bitcoinwas getting hammered,most recently down 6.5%to $35,207.50 as investors shed risk.“Investors should expect strong sanctions imposed on Russia, which will slow growth and leave upward pressure on commodity prices,” wrote Dennis DeBusschere of 22V Research. “How long this crisis takes to unfold will determine how much inflation, financial conditions, and growth will be impacted. Short-term, a flight to safety means Treasury yields, rate hike expectations and risk assets are sharply lower.”The Ukraine situation has added to tensions for the market, which had been worried about tighter Federal Reserve policy amid escalating inflation. Traders have adjusted their views on the Fed in recent days, with the likelihood of a 0.5 percentage point interest rate hike in March down to 17%, according to CME Group data.Wednesday marked another downbeat market session on Wall Street, as traders grappled with the ongoing Russia-Ukraine conflict.In the Wednesday session, the Dow dropped about 464 points, or 1.3%, and closed at its lowest level of 2022 so far. The S&P 500 fell 1.8%, moving deeper into correction and ending the day about 12% from its Jan. 3 record close. The tech-heavy Nasdaq Composite lost 2.6% and now sits close to bear market territory.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":4664,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"content":"buckle up","text":"buckle up","html":"buckle up"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9030339300,"gmtCreate":1645628514862,"gmtModify":1676534046941,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Where tsla","listText":"Where tsla","text":"Where tsla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030339300","repostId":"1180904559","repostType":4,"repost":{"id":"1180904559","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1645627962,"share":"https://ttm.financial/m/news/1180904559?lang=en_US&edition=fundamental","pubTime":"2022-02-23 22:52","market":"us","language":"en","title":"EV Stocks Rebounded in Morning Trading, with TuSimple Rising Nearly 5% and General Motors,Li Rising Around 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180904559","media":"Tiger Newspress","summary":"EV stocks rebounded in morning trading, with TuSimple rising nearly 5% and General Motors,Li rising ","content":"<html><head></head><body><p>EV stocks rebounded in morning trading, with TuSimple rising nearly 5% and General Motors,Li rising around 2%.<img src=\"https://static.tigerbbs.com/938415d3ea3640875c756ff17be3868e\" tg-width=\"314\" tg-height=\"167\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Rebounded in Morning Trading, with TuSimple Rising Nearly 5% and General Motors,Li Rising Around 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Rebounded in Morning Trading, with TuSimple Rising Nearly 5% and General Motors,Li Rising Around 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-23 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks rebounded in morning trading, with TuSimple rising nearly 5% and General Motors,Li rising around 2%.<img src=\"https://static.tigerbbs.com/938415d3ea3640875c756ff17be3868e\" tg-width=\"314\" tg-height=\"167\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","LI":"理想汽车"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180904559","content_text":"EV stocks rebounded in morning trading, with TuSimple rising nearly 5% and General Motors,Li rising around 2%.","news_type":1,"symbols_score_info":{"TSP":0.9,"LI":0.9,"GM":0.9}},"isVote":1,"tweetType":1,"viewCount":4999,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4103876519949130","authorId":"4103876519949130","name":"Raman Singh","avatar":"https://community-static.tradeup.com/news/90557207d6d1edadb4379b6cb9f93f83","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4103876519949130","idStr":"4103876519949130"},"content":"I feel they are overvalued, but Ark keep buring more. So condused what to do. Follow the big guys or play where i unders tand?","text":"I feel they are overvalued, but Ark keep buring more. So condused what to do. Follow the big guys or play where i unders tand?","html":"I feel they are overvalued, but Ark keep buring more. So condused what to do. Follow the big guys or play where i unders tand?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9097442136,"gmtCreate":1645542105533,"gmtModify":1676534037688,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9097442136","repostId":"2213958877","repostType":4,"isVote":1,"tweetType":1,"viewCount":4692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9097616538,"gmtCreate":1645440044033,"gmtModify":1676534027763,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Moon","listText":"Moon","text":"Moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9097616538","repostId":"1177913484","repostType":4,"isVote":1,"tweetType":1,"viewCount":4564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094583980,"gmtCreate":1645182478932,"gmtModify":1676534006485,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094583980","repostId":"1150510845","repostType":4,"repost":{"id":"1150510845","kind":"news","pubTimestamp":1645181612,"share":"https://ttm.financial/m/news/1150510845?lang=en_US&edition=fundamental","pubTime":"2022-02-18 18:53","market":"us","language":"en","title":"Bristol Myers' Breyanzi Gets FDA Priority Review for Expanded Use in Blood Cancer Subtype","url":"https://stock-news.laohu8.com/highlight/detail?id=1150510845","media":"Seeking Alpha","summary":"The U.S. Food and Drug Administration (FDA) granted priority review for expanded use of Bristol Myer","content":"<html><head></head><body><p>The U.S. Food and Drug Administration (FDA) granted priority review for expanded use of <a href=\"https://laohu8.com/S/BMY\">Bristol Myers Squibb's </a> Breyanzi as a second line treatment of adults with relapsed or refractory large B-cell lymphoma (LBCL) after failure of first-line therapy.</p><p>The FDA is expected to make a decision by June 24.</p><p>The company's supplemental biologics license application was backed by data from a phase 3 trial, dubbed TRANSFORM.</p><p>The company said that in the trial Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years.</p><p>Breyanzi is approved in the U.S. to treat adult patients with relapsed or refractory LBCL after two or more lines of systemic therapy.</p><p>The drug also carries a Boxed Warning for the risks of cytokine release syndrome and neurologic toxicities and is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the BREYANZI REMS.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bristol Myers' Breyanzi Gets FDA Priority Review for Expanded Use in Blood Cancer Subtype</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBristol Myers' Breyanzi Gets FDA Priority Review for Expanded Use in Blood Cancer Subtype\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-18 18:53 GMT+8 <a href=https://seekingalpha.com/news/3801835-bristol-myers-breyanzi-gets-fda-priority-review-for-expanded-use-in-blood-cancer-subtype><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.S. Food and Drug Administration (FDA) granted priority review for expanded use of Bristol Myers Squibb's Breyanzi as a second line treatment of adults with relapsed or refractory large B-cell ...</p>\n\n<a href=\"https://seekingalpha.com/news/3801835-bristol-myers-breyanzi-gets-fda-priority-review-for-expanded-use-in-blood-cancer-subtype\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝"},"source_url":"https://seekingalpha.com/news/3801835-bristol-myers-breyanzi-gets-fda-priority-review-for-expanded-use-in-blood-cancer-subtype","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150510845","content_text":"The U.S. Food and Drug Administration (FDA) granted priority review for expanded use of Bristol Myers Squibb's Breyanzi as a second line treatment of adults with relapsed or refractory large B-cell lymphoma (LBCL) after failure of first-line therapy.The FDA is expected to make a decision by June 24.The company's supplemental biologics license application was backed by data from a phase 3 trial, dubbed TRANSFORM.The company said that in the trial Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years.Breyanzi is approved in the U.S. to treat adult patients with relapsed or refractory LBCL after two or more lines of systemic therapy.The drug also carries a Boxed Warning for the risks of cytokine release syndrome and neurologic toxicities and is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the BREYANZI REMS.","news_type":1,"symbols_score_info":{"BMY":0.9}},"isVote":1,"tweetType":1,"viewCount":4800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094807948,"gmtCreate":1645103491490,"gmtModify":1676533997161,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094807948","repostId":"1159532879","repostType":4,"repost":{"id":"1159532879","kind":"news","pubTimestamp":1645102000,"share":"https://ttm.financial/m/news/1159532879?lang=en_US&edition=fundamental","pubTime":"2022-02-17 20:46","market":"us","language":"en","title":"Walmart Bucks Supply-Chain Snarls With Upbeat Annual Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1159532879","media":"Bloomberg","summary":"(Bloomberg) -- Walmart Inc. surpassed Wall Street’s quarterly profit expectations and unveiled an up","content":"<html><head></head><body><p>(Bloomberg) -- Walmart Inc. surpassed Wall Street’s quarterly profit expectations and unveiled an upbeat sales outlook for the current fiscal year despite persistent cost pressures and flagging consumer sentiment.</p><p>Comparable sales at U.S. Walmart stores will post a percentage gain “slightly above 3%” excluding fuel during the current fiscal year, which ends in early 2023, the retailer said in a statement Thursday as it reported earnings. That suggests a better performance than the 2.7% average gain expected by analysts.</p><p>The results underscore Walmart’s efforts to navigate scarce transportation capacity, a labor squeeze and rising fuel costs that are combining with robust demand to spur the fastest growth in U.S. consumer prices in four decades. U.S. retail sales in January rose the most in 10 months, signaling resilient demand despite surging inflation and the weakest consumer confidence in a decade.</p><p>The shares rose 2.7% in premarket trading at 7:36 a.m. New York time. Walmart had fallen 7.7% this year through Wednesday, compared with a 2.4% drop in an S&P index of consumer staples companies. Last year, Walmart dramatically underperformed retail stock indexes and rivals such as Target Corp. and Costco Wholesale Corp.</p><p>The results are likely to be seen as a bellwether as other large U.S. retailers prepare to release earnings. Home Depot Inc., Macy’s Inc. and Lowe’s Cos. report next week, followed the week after by Target, Costco and Best Buy Co.</p><p>Walmart leaders are scheduled to discuss the company’s fourth-quarter results and outlook for this year on a conference call at 8 a.m. New York time.</p><p>Walmart’s adjusted earnings climbed to $1.53 a share in the fiscal fourth quarter, which ended in late January. That topped the $1.51 average of analyst estimates compiled by Bloomberg. Revenue rose 0.5% to $152.9 billion, while Wall Street had expected $151.7 billion.</p><p>The Bentonville, Arkansas-based retailer, which for decades has based its strategy on everyday low prices, is vying for more customers as the rising inflation rate prompts shoppers to look harder for bargains. But higher costs for merchandise, transportation and labor pose a growing threat to profitability.</p><p>That’s raising the stakes as Walmart and other retailers decide how much vendor price increases they will pass along to consumers. Last quarter, comparable sales at Walmart’s U.S. stores rose 5.6% with market share gains in the grocery business, while analysts had predicted 5.5%.</p><p>Walmart is also trying to develop businesses in digital advertising, financial services and health care, and it’s investing heavily in e-commerce. The company is planning capital expenditures in the current fiscal year to be at the upper end of 2.5% to 3% of net sales with a focus on supply chain, automation, customer-facing initiatives and technology.</p><p>Walmart’s U.S. e-commerce sales, a closely watched metric, rose 1% in the fourth quarter while analysts were looking for a 2.2% gain. Online sales got a substantial boost during pandemic lockdowns, but demand has been slowing as shoppers venture back into stores.</p><p>To further boost its e-commerce business, the retailer last year debuted Walmart+, an online subscription offering, to compete with Amazon.com Inc.’s Prime program. Walmart has said little about the initiative’s performance, even downplaying its importance.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Walmart Bucks Supply-Chain Snarls With Upbeat Annual Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWalmart Bucks Supply-Chain Snarls With Upbeat Annual Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-17 20:46 GMT+8 <a href=https://finance.yahoo.com/news/walmart-bucks-supply-chain-snarls-123641490.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Walmart Inc. surpassed Wall Street’s quarterly profit expectations and unveiled an upbeat sales outlook for the current fiscal year despite persistent cost pressures and flagging ...</p>\n\n<a href=\"https://finance.yahoo.com/news/walmart-bucks-supply-chain-snarls-123641490.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛"},"source_url":"https://finance.yahoo.com/news/walmart-bucks-supply-chain-snarls-123641490.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159532879","content_text":"(Bloomberg) -- Walmart Inc. surpassed Wall Street’s quarterly profit expectations and unveiled an upbeat sales outlook for the current fiscal year despite persistent cost pressures and flagging consumer sentiment.Comparable sales at U.S. Walmart stores will post a percentage gain “slightly above 3%” excluding fuel during the current fiscal year, which ends in early 2023, the retailer said in a statement Thursday as it reported earnings. That suggests a better performance than the 2.7% average gain expected by analysts.The results underscore Walmart’s efforts to navigate scarce transportation capacity, a labor squeeze and rising fuel costs that are combining with robust demand to spur the fastest growth in U.S. consumer prices in four decades. U.S. retail sales in January rose the most in 10 months, signaling resilient demand despite surging inflation and the weakest consumer confidence in a decade.The shares rose 2.7% in premarket trading at 7:36 a.m. New York time. Walmart had fallen 7.7% this year through Wednesday, compared with a 2.4% drop in an S&P index of consumer staples companies. Last year, Walmart dramatically underperformed retail stock indexes and rivals such as Target Corp. and Costco Wholesale Corp.The results are likely to be seen as a bellwether as other large U.S. retailers prepare to release earnings. Home Depot Inc., Macy’s Inc. and Lowe’s Cos. report next week, followed the week after by Target, Costco and Best Buy Co.Walmart leaders are scheduled to discuss the company’s fourth-quarter results and outlook for this year on a conference call at 8 a.m. New York time.Walmart’s adjusted earnings climbed to $1.53 a share in the fiscal fourth quarter, which ended in late January. That topped the $1.51 average of analyst estimates compiled by Bloomberg. Revenue rose 0.5% to $152.9 billion, while Wall Street had expected $151.7 billion.The Bentonville, Arkansas-based retailer, which for decades has based its strategy on everyday low prices, is vying for more customers as the rising inflation rate prompts shoppers to look harder for bargains. But higher costs for merchandise, transportation and labor pose a growing threat to profitability.That’s raising the stakes as Walmart and other retailers decide how much vendor price increases they will pass along to consumers. Last quarter, comparable sales at Walmart’s U.S. stores rose 5.6% with market share gains in the grocery business, while analysts had predicted 5.5%.Walmart is also trying to develop businesses in digital advertising, financial services and health care, and it’s investing heavily in e-commerce. The company is planning capital expenditures in the current fiscal year to be at the upper end of 2.5% to 3% of net sales with a focus on supply chain, automation, customer-facing initiatives and technology.Walmart’s U.S. e-commerce sales, a closely watched metric, rose 1% in the fourth quarter while analysts were looking for a 2.2% gain. Online sales got a substantial boost during pandemic lockdowns, but demand has been slowing as shoppers venture back into stores.To further boost its e-commerce business, the retailer last year debuted Walmart+, an online subscription offering, to compete with Amazon.com Inc.’s Prime program. Walmart has said little about the initiative’s performance, even downplaying its importance.","news_type":1,"symbols_score_info":{"WMT":0.9}},"isVote":1,"tweetType":1,"viewCount":4498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095472787,"gmtCreate":1644980502284,"gmtModify":1676533983142,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095472787","repostId":"1128199198","repostType":4,"repost":{"id":"1128199198","kind":"news","pubTimestamp":1644979615,"share":"https://ttm.financial/m/news/1128199198?lang=en_US&edition=fundamental","pubTime":"2022-02-16 10:46","market":"us","language":"en","title":"Two Reasons to Skip Ocugen Stock Despite Some Good News","url":"https://stock-news.laohu8.com/highlight/detail?id=1128199198","media":"InvestorPlace","summary":"Ocugen(NASDAQ:OCGN) has been one of the most explosive stocks on the market in the last year.From a ","content":"<div>\n<p>Ocugen(NASDAQ:OCGN) has been one of the most explosive stocks on the market in the last year.From a December 2020 low of about 29 cents, the OCGN stock exploded to a high of $17.65 in recent months ...</p>\n\n<a href=\"https://investorplace.com/2022/02/two-reasons-to-skip-ocugen-stock-despite-some-good-news/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Two Reasons to Skip Ocugen Stock Despite Some Good News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwo Reasons to Skip Ocugen Stock Despite Some Good News\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-16 10:46 GMT+8 <a href=https://investorplace.com/2022/02/two-reasons-to-skip-ocugen-stock-despite-some-good-news/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ocugen(NASDAQ:OCGN) has been one of the most explosive stocks on the market in the last year.From a December 2020 low of about 29 cents, the OCGN stock exploded to a high of $17.65 in recent months ...</p>\n\n<a href=\"https://investorplace.com/2022/02/two-reasons-to-skip-ocugen-stock-despite-some-good-news/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2022/02/two-reasons-to-skip-ocugen-stock-despite-some-good-news/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128199198","content_text":"Ocugen(NASDAQ:OCGN) has been one of the most explosive stocks on the market in the last year.From a December 2020 low of about 29 cents, the OCGN stock exploded to a high of $17.65 in recent months for a return of just under 6,000%.It’s all thanks to its coronavirus vaccine, Covaxin.Co-developed with India’s Bharat Biotech, the vaccine had a 77.8% overall efficacy rate in a phase-3 study. In addition, the World Health Organization issued emergency use authorization for the vaccine to be used globally.Also, “previous studies showed that Covaxin was also effective at immunizing patients against the Alpha, Beta, Delta, Zeta, and Kappa variants of Covid-19,” as noted by TipRanks.That’s all great news.No wonder Noble Financial analyst Robert LeBoyer has an outperform rating on the stock, with a price target of $15 a share.However, I wouldn’t rush to buy the stock. There are some major issues.Issue No. 1: Ocugen’s Commercialization Agreement with Bharat BiotechAt the moment, Ocugen has a commercialization agreement with Bharat Biotech that only includes the United States and Canada.That means OCGN only makes money from the vaccine from sales in the U.S. and Canada. Worse, the company hasn’t received authorization from either country. Plus, even if it did receive authorization, the U.S. already has vaccines in use.Issue No. 2: OCGN Stock is Losing MoneyWorse, the company isn’t bringing in any money, and losses continue to pile up.In its third quarter, the company had no revenue. Plus, in the first nine months of 2021, it posted a net earnings loss of $43.78 million. That was worse than the $30.58 million posted year over year. Plus, according to Motley Fool contributor David Jagielski:“Over the same time frame, Ocugen has used up $35.1 million on just its day-to-day operating activities. That’s problematic given that the cash Ocugen reported at the end of the period was just $107.5 million.”Fortunately, the Vaccine Isn’t Ocugen’s Only CatalystThat being said, Ocugen is in pre-clinical trials for dry age-related macular degeneration, diabetic macular edema, diabetic retinopathy and wet age-related macular degeneration.In addition, the U.S. Food and Drug Administration recently accepted the company’s Investigational New Drug application (IND) to initiate clinical trials of its gene therapy treatment for retinitis pigmentosa.Also, according to a company press release, “The European Medicines Agency (EMA) granted Ocugen broad orphan medicinal product designation in 2021 for OCU400 for the treatment of both retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) — meaning that, if approved, OCU400 by itself could treat these diseases that are rooted in mutations of more than 175 different genes.”The Bottom Line on OCGN StockThe story behind OCGN certainly is solid; there’s some good news with its phase-3 vaccine trials.Plus, analyst price targets on the stock have an average of $8.88, with one analyst giving it a target price of $15.Unfortunately, it’s burning through cash. It’s not generating revenues. In addition, unless it can get emergency use authorization in the U.S. and Canada, it’s not likely to make money. Coupled with fierce coronavirus vaccine competition, the existing agreement with Bharat Biotech isn’t actually good for the company.I just don’t see how the OCGN stock could come anywhere near $15 a share on that. For now, avoid the stock. Unless some miracle happens, OCGN stock should be avoided.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":3935,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095207977,"gmtCreate":1644917121317,"gmtModify":1676533975375,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Oof","listText":"Oof","text":"Oof","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095207977","repostId":"1137786012","repostType":2,"repost":{"id":"1137786012","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644916695,"share":"https://ttm.financial/m/news/1137786012?lang=en_US&edition=fundamental","pubTime":"2022-02-15 17:18","market":"us","language":"en","title":"Larimar Therapeutics Shares Tumbled 54.6% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137786012","media":"Tiger Newspress","summary":"Larimar Therapeutics shares tumbled 54.6% in premarket trading.Larimar Therapeutics, Inc. (“Larimar”","content":"<html><head></head><body><p>Larimar Therapeutics shares tumbled 54.6% in premarket trading.<img src=\"https://static.tigerbbs.com/5e316cacb1c57749759d7b0f849e22cc\" tg-width=\"711\" tg-height=\"610\" referrerpolicy=\"no-referrer\"/>Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced that it has received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimar’s CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agency’s request.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Larimar Therapeutics Shares Tumbled 54.6% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLarimar Therapeutics Shares Tumbled 54.6% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-15 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Larimar Therapeutics shares tumbled 54.6% in premarket trading.<img src=\"https://static.tigerbbs.com/5e316cacb1c57749759d7b0f849e22cc\" tg-width=\"711\" tg-height=\"610\" referrerpolicy=\"no-referrer\"/>Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced that it has received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimar’s CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agency’s request.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137786012","content_text":"Larimar Therapeutics shares tumbled 54.6% in premarket trading.Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced that it has received feedback from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on Larimar’s CTI-1601 program. FDA stated it is maintaining its clinical hold at this time and that additional data is needed to resolve the clinical hold. Larimar is further analyzing previously completed studies, and is evaluating if additional studies are warranted. The Company also intends to engage FDA to determine how best to provide these data. Larimar is currently reassessing guidance on the timing of the planned Jive open-label extension and pediatric multiple-ascending dose clinical trials as it works to meet the agency’s request.","news_type":1,"symbols_score_info":{"LRMR":0.9}},"isVote":1,"tweetType":1,"viewCount":4756,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095317416,"gmtCreate":1644823536056,"gmtModify":1676533965308,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095317416","repostId":"2211209385","repostType":4,"isVote":1,"tweetType":1,"viewCount":4837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092667216,"gmtCreate":1644623440311,"gmtModify":1676533946610,"author":{"id":"3571707309049146","authorId":"3571707309049146","name":"benjaminlsk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571707309049146","idStr":"3571707309049146"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092667216","repostId":"1135407149","repostType":4,"repost":{"id":"1135407149","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644590978,"share":"https://ttm.financial/m/news/1135407149?lang=en_US&edition=fundamental","pubTime":"2022-02-11 22:49","market":"us","language":"en","title":"Under Armour Shares Slid 7% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1135407149","media":"Tiger Newspress","summary":"Under Armour Class A/C Shares Both Slid 7% in Morning Trading. Under Armour Warned of Margin Hit Du","content":"<html><head></head><body><p>Under Armour Class A/C Shares Both Slid 7% in Morning Trading. Under Armour Warned of Margin Hit Due to Higher Freight Expenses.</p><p><img src=\"https://static.tigerbbs.com/684c26d2a420b4f84e6cc9263c599132\" tg-width=\"879\" tg-height=\"642\" width=\"100%\" height=\"auto\"/><a href=\"https://laohu8.com/S/UA\">Under Armour Inc</a> on Friday warned that its profit margin would be under pressure in the current quarter, as the sportswear maker incurs high transportation costs due to COVID-19-led disruptions to its supply chain.</p><p>Corporate America has raised prices of everything from burgers to hoodies to offset the pandemic-led inflation across the supply chain from labor to raw materials, but many companies could not fully offset the impact.</p><p>Under Armour has been forced to use pricier air freight to bring in its products from its manufacturing hubs in Asia to ensure its shelves are sufficiently stocked.</p><p>The company said on Friday its gross margin would be down 200 basis points in the quarter ending March 31, compared with last year's adjusted gross margin, hurt by a 240 basis points hit from higher freight expenses.</p><p>Under Armour added that supply chain constraints forced it to reduce its orders for spring-summer of 2022, as many factories that make its clothing are only just recovering from COVID-19 outbreaks and employee shortages.</p><p>However, strong demand for its athletic wear during the holiday season and higher prices of its hoodies and leggings helped it beat revenue estimates for the quarter ended Dec. 31.</p><p>The company's net revenue rose to $1.53 billion in the quarter ended Dec. 31, from $1.40 billion, a year earlier. Analysts polled by Refinitiv were expecting $1.47 billion.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Under Armour Shares Slid 7% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnder Armour Shares Slid 7% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-11 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Under Armour Class A/C Shares Both Slid 7% in Morning Trading. Under Armour Warned of Margin Hit Due to Higher Freight Expenses.</p><p><img src=\"https://static.tigerbbs.com/684c26d2a420b4f84e6cc9263c599132\" tg-width=\"879\" tg-height=\"642\" width=\"100%\" height=\"auto\"/><a href=\"https://laohu8.com/S/UA\">Under Armour Inc</a> on Friday warned that its profit margin would be under pressure in the current quarter, as the sportswear maker incurs high transportation costs due to COVID-19-led disruptions to its supply chain.</p><p>Corporate America has raised prices of everything from burgers to hoodies to offset the pandemic-led inflation across the supply chain from labor to raw materials, but many companies could not fully offset the impact.</p><p>Under Armour has been forced to use pricier air freight to bring in its products from its manufacturing hubs in Asia to ensure its shelves are sufficiently stocked.</p><p>The company said on Friday its gross margin would be down 200 basis points in the quarter ending March 31, compared with last year's adjusted gross margin, hurt by a 240 basis points hit from higher freight expenses.</p><p>Under Armour added that supply chain constraints forced it to reduce its orders for spring-summer of 2022, as many factories that make its clothing are only just recovering from COVID-19 outbreaks and employee shortages.</p><p>However, strong demand for its athletic wear during the holiday season and higher prices of its hoodies and leggings helped it beat revenue estimates for the quarter ended Dec. 31.</p><p>The company's net revenue rose to $1.53 billion in the quarter ended Dec. 31, from $1.40 billion, a year earlier. Analysts polled by Refinitiv were expecting $1.47 billion.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UA":"安德玛公司C类股","UAA":"安德玛公司A类股"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135407149","content_text":"Under Armour Class A/C Shares Both Slid 7% in Morning Trading. Under Armour Warned of Margin Hit Due to Higher Freight Expenses.Under Armour Inc on Friday warned that its profit margin would be under pressure in the current quarter, as the sportswear maker incurs high transportation costs due to COVID-19-led disruptions to its supply chain.Corporate America has raised prices of everything from burgers to hoodies to offset the pandemic-led inflation across the supply chain from labor to raw materials, but many companies could not fully offset the impact.Under Armour has been forced to use pricier air freight to bring in its products from its manufacturing hubs in Asia to ensure its shelves are sufficiently stocked.The company said on Friday its gross margin would be down 200 basis points in the quarter ending March 31, compared with last year's adjusted gross margin, hurt by a 240 basis points hit from higher freight expenses.Under Armour added that supply chain constraints forced it to reduce its orders for spring-summer of 2022, as many factories that make its clothing are only just recovering from COVID-19 outbreaks and employee shortages.However, strong demand for its athletic wear during the holiday season and higher prices of its hoodies and leggings helped it beat revenue estimates for the quarter ended Dec. 31.The company's net revenue rose to $1.53 billion in the quarter ended Dec. 31, from $1.40 billion, a year earlier. Analysts polled by Refinitiv were expecting $1.47 billion.","news_type":1,"symbols_score_info":{"UA":0.9,"UAA":0.9}},"isVote":1,"tweetType":1,"viewCount":4547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}